Charles Sheedy Insider Profile
4 Followers
Charles Sheedy, Ten Percent Owner at Nuo Therapeutics, holds 11.57M shares in Nuo Therapeutics (Ticker: AURX), holds 752.35K shares in Acer Therapeutics (Ticker: ACER). Most recently, Charles Sheedy Bought ― shares of Nuo Therapeutics on Aug 01, 2025 for an estimated value of $200.00K.
Charles Sheedy Nuo Therapeutics (AURX)Ten Percent Owner
Nuo Therapeutics (AURX)
Ten Percent Owner
Ranked #474 out of 108,699 Corporate Insiders
Profitable Transactions
4 out of 7 Profitable Transactions
Average Return
+157.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
Ten Percent Owner
Roles that Charles Sheedy holds in companies
Most Profitable Insider Trade
The most profitable trade made by Charles Sheedy
Charles Sheedy's Trading History
Nuo Therapeutics
Aug 01, 2025
Ten Percent Owner
Informative Buy
200.00K
$12.38M
Acer Therapeutics
Jul 23, 2009
―
Informative Buy
―
$496.55K
List of latest transactions for each holding click on a transaction to see Charles Sheedy's performance on stock
You May Also Like
Charles Sheedy insider profile FAQ
What is the percentage of profitable transactions made by Charles Sheedy?
The percentage of profitable transactions made by Charles Sheedy is 57%.
What is the average return per transaction made by Charles Sheedy?
The average return per transaction made by Charles Sheedy is 157.70%.
What stocks does Charles Sheedy hold?
Charles Sheedy holds: AURX, ACER stocks.
What was Charles Sheedy’s latest transaction?
Charles Sheedy latest transaction was an Informative Buy of $200.00K.
What was Charles Sheedy's most profitable transaction?
Charles Sheedy’s most profitable transaction was an Informative Buy of AURX stock on May 2, 2022. The return on the trade was 800.00%.
What is Charles Sheedy's role in Nuo Therapeutics?
Charles Sheedy's role in Nuo Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.